Biocartis Group NV (CHIX:BCARTB) Institutional Ownership : 5.23% (As of Jun. 19, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Biocartis Group NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biocartis Group NV's institutional ownership is 5.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biocartis Group NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biocartis Group NV's Float Percentage Of Total Shares Outstanding is 0.00%.

Biocartis Group NV Institutional Ownership Historical Data

The historical data trend for Biocartis Group NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocartis Group NV Institutional Ownership Chart

Biocartis Group NV Historical Data

The historical data trend for Biocartis Group NV can be seen below:

	2024-03-31	2024-04-30	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31
Institutional Ownership	5.20	5.20	5.20	5.22	5.22	5.22	5.23	5.23	5.23	5.23

Biocartis Group NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Biocartis Group NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocartis Group NV (CHIX:BCARTb) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Generaal de Wittelaan 11 B, Mechelen, BEL, 2800

Website

https://www.biocartis.com

Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.

Biocartis Group NV Headlines

No Headlines